SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tatnic who wrote (1158)10/21/1999 9:30:00 PM
From: Hank   of 5582
 
Well, you're probably right in being skeptical. I think that most people today are always in search of the quick fix, just like they're always looking for the quick buck. I really don't think most people will have the patience to stick with Zicam if it doesn't make them feel better right away. I know I sure wouldn't have if I knew nothing about the way in which Zicam is supposed to work and was just trying it on a whim. Maybe if GUMM can pull off a marketing miracle and get one of the big drug companies to co-market zicam with one of the more traditional medicines they'll have a chance. Maybe something like- buy a bottle of Nyquil and get a bottle of Zicam for $4. That, combined with more explicit package literature, may get people to try the stuff and stick with it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News